266 related articles for article (PubMed ID: 9525590)
1. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
Sandefur S; Varthakavi V; Spearman P
J Virol; 1998 Apr; 72(4):2723-32. PubMed ID: 9525590
[TBL] [Abstract][Full Text] [Related]
2. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
Sandefur S; Smith RM; Varthakavi V; Spearman P
J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
[TBL] [Abstract][Full Text] [Related]
3. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
Spearman P; Wang JJ; Vander Heyden N; Ratner L
J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
[TBL] [Abstract][Full Text] [Related]
4. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
[TBL] [Abstract][Full Text] [Related]
5. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions.
Derdowski A; Ding L; Spearman P
J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278
[TBL] [Abstract][Full Text] [Related]
6. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
Spearman P; Horton R; Ratner L; Kuli-Zade I
J Virol; 1997 Sep; 71(9):6582-92. PubMed ID: 9261380
[TBL] [Abstract][Full Text] [Related]
7. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
Zhou W; Parent LJ; Wills JW; Resh MD
J Virol; 1994 Apr; 68(4):2556-69. PubMed ID: 8139035
[TBL] [Abstract][Full Text] [Related]
8. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.
Zhang Y; Qian H; Love Z; Barklis E
J Virol; 1998 Mar; 72(3):1782-9. PubMed ID: 9499028
[TBL] [Abstract][Full Text] [Related]
10. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
Zhang Y; Barklis E
J Virol; 1997 Sep; 71(9):6765-76. PubMed ID: 9261401
[TBL] [Abstract][Full Text] [Related]
11. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein.
Zhou W; Resh MD
J Virol; 1996 Dec; 70(12):8540-8. PubMed ID: 8970978
[TBL] [Abstract][Full Text] [Related]
12. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
Ono A; Demirov D; Freed EO
J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
[TBL] [Abstract][Full Text] [Related]
13. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain.
Platt EJ; Haffar OK
Proc Natl Acad Sci U S A; 1994 May; 91(10):4594-8. PubMed ID: 8183954
[TBL] [Abstract][Full Text] [Related]
15. Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts.
Ding L; Derdowski A; Wang JJ; Spearman P
J Virol; 2003 Feb; 77(3):1916-26. PubMed ID: 12525626
[TBL] [Abstract][Full Text] [Related]
16. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
Cimarelli A; Luban J
J Virol; 2000 Aug; 74(15):6734-40. PubMed ID: 10888611
[TBL] [Abstract][Full Text] [Related]
18. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
González SA; Affranchino JL
Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
Bouyac M; Courcoul M; Bertoia G; Baudat Y; Gabuzda D; Blanc D; Chazal N; Boulanger P; Sire J; Vigne R; Spire B
J Virol; 1997 Dec; 71(12):9358-65. PubMed ID: 9371595
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
